🇺🇸 FDA
Pipeline program

self-expandable 125I radioactive seeds-loaded-stent

320924197612177170-BS

Phase 2 other completed

Quick answer

self-expandable 125I radioactive seeds-loaded-stent for Cholangiocellular Carcinoma is a Phase 2 program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Cholangiocellular Carcinoma
Phase
Phase 2
Modality
other
Status
completed

Clinical trials